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Abstract Background: The relationship between chronic
myeloid leukemia (CML) and a broad range of exposures
to occupational and environmental factors known to cause
leukemia in general is limited. CML is by and large incur-
able and treatment is just palliative and life prolonging, with
high case fatality rate, even in the best centers. Furthermore
treatment is very expensive. Identification of leukemogenic
factors is therefore important if this can lead to simple public
health interventions.
Objective: The objective was to determine key environmen-
tal and occupational exposure factors that may be associated
with CML.
Methods: This was a case-control study involving CML
cases enrolled in Glivec International Patient Assistance Pro-
gram (GIPAP) clinics at the Nairobi Hospital and Aga Khan
University Hospital and two control groups for each case,
matched for age and sex: a family- and hospital-based con-
trol, was carried out. One hundred and eight cases with age-
and-gender-matched family- and hospital-based controls
were recruited and a standard questionnaire was adminis-
tered. Individual data on demographics, occupation, envi-
ronment, and exposures to benzene and farm organochem-
ical products were obtained. Clinical examination was
carried out in control subjects. Statistical analysis was done
using bivariate and multivariate analysis to look for associa-
tions between exposure factors and CML.
Results: The median age at diagnosis of CML cases was
41.32 years with an age range of 8–81 years and a male to
female ratio of 1.7:1. Most of our cases were concentrated in
or around Nairobi. There was no significant correlation
found for exposure to benzene or pesticides. Long duration
of exposure to pesticides in the family control group was
significantly associated (t-test, P = 0.017) with risk of CML.
Conclusions: Associations between exposures to organic
solvents like pesticides and CML were indicated but were
not entirely consistent, although no associations with ben-
zene products were found. Nevertheless, for almost all
cases of Ph chromosome-positive CML, other explanations
must be sought for.
Keywords Chronic myeloid leukemia · Environmental and
occupational factors
Résumé Contexte : La relation entre la leucémie myéloïde
chronique (LMC) et de nombreuses expositions différentes à
des facteurs environnementaux et professionnels connus
pour causer une leucémie de manière générale est limitée.
Dans l’ensemble, la LMC est incurable et le traitement ne
constitue qu’une solution palliative permettant de prolonger
la vie, avec un taux de létalité très élevé, même dans les
meilleurs centres. En outre, son traitement est extrêmement
onéreux. L’identification des facteurs leucémogènes est par
conséquent importante si elle permet de recourir à de simples
interventions de santé publique.
Objectif : L’objectif était de déterminer les facteurs clés
d’exposition environnementale et professionnelle pouvant
être associés à la LMC.
Méthodes : Il s’agissait d’une étude de cas-témoins impli-
quant des cas de LMC déclarés dans des cliniques du
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programme GIPAP à l’hôpital de Nairobi et à l’hôpital uni-
versitaire Aga-Khan ainsi que deux groupes témoins pour
chaque cas, regroupés en fonction de l’âge et du sexe : une
étude de cas-témoins a été réalisée en milieu familial et en
milieu hospitalier. Parmi les études en milieu familial et hos-
pitalier regroupées en fonction de l’âge et du sexe, 108 cas
ont été recrutés et soumis à un questionnaire standard. Des
données individuelles concernant des expositions démogra-
phiques, professionnelles et environnementales à du benzène
ainsi qu’à des produits chimiques organiques agricoles ont
été obtenues. Des examens cliniques ont été réalisés sur les
sujets témoins. Une analyse statistique a été effectuée à
l’aide d’analyses bivariées et multivariées afin de rechercher
des liens entre les facteurs d’exposition et la LMC.
Résultats : L’âge médian lors du diagnostic des cas de LMC
était de 41,32 ans sur une amplitude de 8 à 81 ans et un
rapport hommes–femmes de 1,7/1. La plupart de nos cas
étaient concentrés à Nairobi ou dans ses alentours. Aucune
corrélation significative n’a été établie pour les expositions
au benzène ou aux pesticides. Une exposition de longue
durée à des pesticides dans le groupe témoin en milieu famil-
ial était très fortement associée (test de Student, p = 0,017)
au risque de LMC.
Conclusions : Des liens entre les expositions à des solvants
organiques tels que des pesticides et la LMC ont été indiqués
mais n’étaient pas totalement cohérents, bien qu’aucune
association avec des produits au benzène n’ait été trouvée.
Néanmoins, pour presque tous les cas de Ph+LMC, il est
nécessaire de rechercher d’autres explications.
Mots clés Leucémie myéloïde chronique · Facteurs
envionnementaux et professionnels
Introduction
Chronic myeloid leukemia (CML) runs a stable course for
several years before assuming a rapid downhill progression.
It results from neoplastic proliferation of a multipotential
hematopoetic stem cell. More than 90% of the cases of
CML have Philadelphia (Ph) chromosome-positive leuke-
mic cells replacing marrow cells [1]. This chromosome is
an abnormally short chromosome 22, which results from
reciprocal translocations between chromosomes 9 and 22.
One break occurs at band q34 near the long end of chromo-
some 9 and another in the upper half of chromosome 22 in
the long end at band q11. The translocation breakpoint at
chromosome 9 occurs near the 5’ end of the Abelson (ABL,
c-abl) oncogene, and ABL is, through these events, translo-
cated from its normal location on chromosome 9 to chromo-
some 22. The gene located at the breakpoint of chromosome
22 is termed breakpoint cluster region (BCR) and measures
130 kilobases (kb). A segment of BCR in which the break
occurs is referred to as bcr (small breakpoint cluster region).
The t(9:22)(q34:q11) gene fusion leads to formation of a
chimeric (hybrid) gene, resulting in production of chimeric
mRNAwhich leads to production of a chimeric ABL protein
product which is larger (210 kb) than normal (145 kb). The
mechanism by which this chimeric gene promotes the tran-
sition from benign state to fully malignant involves the resul-
tant increased tyrosine kinase activity, leading to abnormal
proliferation of myeloid cells [2]. This is usually related to
chronic stable phase. After variable periods, other molecular
changes occur, leading to disease progression to accelerated
and blastic phases [1].
Carcinogens bring about neoplastic transformation
through various mechanisms. In the case of CML, they are
responsible for bringing about the mitotic error that leads to
the breaks and aberrant fusions involving chromosomes
9 and 22.
Various chemicals have been implicated in the process of
carcinogenesis. Benzene is one such product. It is used mainly
as a starting material in the synthesis of numerous chemicals.
The main public health issue concerning benzene in the
United States and other developed countries is its use as a
component of gasoline and the fact that the shift to unleaded
gasoline has tended to increase its benzene content [3–6].
Occupational exposure to chemicals, especially solvents
containing benzene, has been associated with leukemia [7].
Workers exposed to benzene with exposures greater than
200 ppm/year have more than 20 times greater risk of devel-
oping acute myeloid leukemia (AML) than the general pop-
ulation [8]. The ability of benzene to cause AML was first
fully established in the 1970s following epidemiological
studies in Italy and Turkey [9–11].
The Ph chromosome was observed by classical cytoge-
netics in a case of preleukemia (leucopenia) resulting from
chronic exposure to benzene for 4 years without the signs of
leukemia. After further 4 years without exposure, the aberra-
tion disappeared [12].
For the data on organic solvents, an effect was found for
moderate or high intensity of exposure (odds ratio (OR) =
3.4, and for long duration (15–20 years) of exposure OR =
2.1) [13].
Pesticides and farm chemicals also contain many carcino-
genic compounds. Aromatic organochlorides include chlor-
ophenoxy pesticides, combustion by-products, such as poly-
chlorinated dibenzo-P-dioxins (PCDDs) and dibenzofurans
(PCDFs), and industrial products, such as polychlorinated
biphenyls (PCBs) and polybrominated biphenyls (PBBs).
These compounds are chemically stable over many decades;
they are passed along food chains, accumulate in fatty tissue,
and are eliminated slowly from the body. Animal studies
have shown that PCBs and DDT are carcinogens at high
doses [14].
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Two reviews have reached similar conclusions regarding
role of pesticides in childhood leukemias. Zalm and Ward
from National Cancer Institute (NCI) concluded in their
review of 17 case-controlled studies and one cohort study
that the literature supports a possible role for pesticides in
development of childhood leukemias [15]. After reviewing
the same literature, Daniels and colleagues in University of
North Carolina concluded that leukemia association was
more consistent among children whose parents had occupa-
tional pesticide exposures than among parents with residen-
tial pesticide exposure [16]. We decided to carry out a survey
to determine the exposure to benzene compounds and farm
chemicals in patients with CML. Our main objective was to
determine key environmental and occupational factors that
may be associated with this disease.
Methods
This was a case-control study in which cases were matched
by age with gender, familial, and hospital control population.
The study sites were Glivec International Patients Assistance
Programme (GIPAP) clinics which run at the Nairobi Hospi-
tal and Aga Khan University Hospitals. This is an assistance
program which provides Ph chromosome-positive patients
with imatinib mesylate (marketed as Gleevec® or Glivec®)
at no cost. The cases and familial controls were recruited at
these clinics.
The hospital controls were recruited from the Kenyatta
National Hospital (KNH) medical outpatient and specialized
clinics.
Patients were considered to suffer from CML if they pre-
sented with suggestive history, usually with features of mas-
sive splenomegaly. Peripheral blood film features of profuse
neutrophil leukocytosis coexisting with increased basophils,
eosinophils, and monocytes with display of full maturation
spectrum of myeloid series (promyelocytes, myelocytes,
metamyelocytes, band forms, and mature elements), con-
firmed by hyper cellular bone marrow with myeloid hyper-
plasia, were the requisite hematologic findings. All patients
were cytogenetically confirmed as Ph chromosome-positive,
which was determined by fluorescent in situ hybridization
(FISH) method. This information was obtained from the
patients’ clinical records.
Hospital controls were patients with a non-malignant,
non-hematological disease with physical examination not
suggestive of any malignancy or hematological disorder
and a normal hemogram parameter (WBC < 11 × 109/L)
and normal morphology of WBC on PBF. They were
patients from medical outpatient clinics in KNH, with any
other medical condition. A familial control was defined as a
family member of the case, being a 1st, 2nd, or 3rd degree
relative.
All CML patients on follow up in GIPAP program were
included and family members who were 1st, 2nd, or 3rd
degree relative of the patient were included as familial
controls.
Those who declined to consent for interview, and controls
suffering from any other malignancy or with abnormal
hemogram were excluded.
A detailed standard questionnaire was administered to
each recruited subject. A lifelong occupational history was
obtained, focusing on all jobs held for at least 1 year, includ-
ing work task, department, and duration of employment. Evi-
dence for specific exposures was enquired about exposure to
benzene and organic solvents by working in petrochemical,
paint, plastic, or motor repair industries, or application of pes-
ticides by working as a gardener, horticulturist, farmer, or
farmhand. The information was recorded in the questionnaire.
All patients attending GIPAP clinics had the details of the
study explained to them, and if they consented, they were
recruited and administered the questionnaire. The systematic
recruitment continued until the desired sample size was
achieved. If the patient was accompanied by an appropriate
familial control subject, he/she was also recruited in the
same fashion; otherwise the patient was requested to bring
an appropriate family member on the next visit.
Each week, a similar number of age and gender matched
hospital controls were also picked from medical outpatient
and specialized clinics, and a search was carried out through
the patients’ files to select appropriate age and gender
matched individuals. Once a control subject was identified,
the study was explained to him/her, and if consent was
obtained, the questionnaire was administered. If no consent
was given, another control was identified in the same way
and the procedure repeated.
Physical examination was performed on all recruited con-
trol subjects to rule out any definite hematological or onco-
logical disorder, with special emphasis on weight loss,
lymphadenopathy or splenomegaly.
After the interview, 2 ml of venous blood was drawn from
cubital veins of the controls for hemogram and peripheral
blood film. This was put in EDTA tubes and analyzed within
8 h in the hematology unit using the Cell Dyne 1300®model
of automated cell counts.
The result of the blood analysis was communicated to the
subject by phone. Subjects with abnormal result were guided
to receive appropriate medical attention and subsequently
excluded from the study.
Data Management and Analysis
Data was entered into MS Access, cleaned and verified. Sta-
tistical analysis of data was undertaken using Statistical
Package for Social Sciences (SPSS) version 11.5. Data was
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presented in the form of tables, graphs, and pie charts.
Descriptive statistics, such as mean, median, and standard
deviation, were determined where applicable. Duration of
exposure, age, and BMI were calculated as continuous vari-
ables. For purposes of diagrammatic presentation, the num-
ber of persons per district and age were used as categorical
variables. Exposure variables were categorized in a binary
format as ever or never exposed. To assess the significance
of differences in continuous data, the t-test was used and for
categorical data, chi-square was used. Comparison of results
using OR with 95% confidence interval was done. Multivar-
iate risk analysis was done using logistic regression. P values
of <0.05 were considered significant. P values in the OR
tables were obtained from chi square tests computed for 2
× 2 tables with appropriate statistical correction where nec-
essary. Data was analyzed and both sets of analysis were
presented separately for each control group to avoid non-
differential bias [17].
Ethical approval to carry out this study was obtained from
Kenyatta National Hospital/University of Nairobi Ethics and
Research Committee (KNH/UON ERC) and patients were
enrolled for study only after giving informed written con-
sent. All information obtained from the study had been han-
dled in confidence and used only for intended purpose.
The only invasive procedure was collection of blood for
full hemogram in the control population. The results of
blood test were communicated to the subjects. In case of
abnormal results in the hemogram of control population,
they were guided for the appropriate clinical interventions.
No extra financial cost was borne by the patients or controls
as they were interviewed when they came for their routine
clinic. The familial controls requested to accompany the
patients were reimbursed their transport costs. Questionnaire
was in simple English which could easily be translated into
Kiswahili or local languages.
Results
A total of 120 cases, 108 familial controls, and 112 hospital
controls were recruited between August 2008 and January
2009.
Twelve cases were excluded for various reasons: two did
not give consent and ten failed to bring appropriate familial
control subjects. Four hospital controls were excluded: two
had a history of suffering from previous malignancy; one
from breast cancer and other one from Kaposi’s sarcoma
and two had elevated WBC counts. One hundred and eight
cases with two controls for each were analyzed. Full hemo-
gram and peripheral blood film was done for all controls
(Fig. 1).
Demographic Characteristics
Patients’ ages ranged from 8 to 81 years with the median age
of 40.5 and mean age of 41.31 ± 15.33. The mean age in
males was 40.35 ± 15.74 while in females was 42.97 ±
14.69. The mean age in familial and hospital control groups
was 41.07 ± 15.21 and 41.2 ± 14.83 with medians of 41.0
and 40.0, respectively.
Sixty-eight (63%) males and 40 (37%) females were
enrolled into the study, with a male to female ratio of 1.7:1,
which is comparable with previous literature [18].
The most prevalent age group for the cases was in the age
bracket of 35–40 years, which was also the most prevalent
age group in males, while in females it was 25–30 years.
Cases with extremes of age, the youngest and oldest patients
were also males (Fig. 2).
The results of the demographic characteristics and body
mass index (BMI) for the three study groups are summarized
in the Table 1.
Fig. 1 Patient flow chart
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Cases and control groups were more involved in indoor
occupations rather than outdoor, although the hospital con-
trol group was more equally distributed (indoor = 56.3% and
outdoor = 43.7%). The familial control group had more
indoor occupations, at 73.5% of the whole group than the
rest (Table 1).
Majority of patients seen came from the vicinity of Nair-
obi city, which was the study site, and its immediate envi-
rons. There were also a high number of patients from Mom-
basa, which is the second largest city in Kenya. Overall, the
cases were mainly from the southern, more populated part of
Kenya except two patients who came from the North Eastern
province. Nine patients had lived out of Kenya at some
points in their life (Fig. 3).
Exposure to Benzene
Thirteen cases were exposed to benzene in terms of working
in petroleum, plastic, and motor repair industries as compared
to 21 individuals in familial control group and 15 patients in
hospital control group. There were 4 (3.7%) cases and 4 con-
trols in each group exposed to petroleum, giving an OR of
unity. Two cases (1.9%) and two familial controls, with no
hospital control, were exposed to plastic industry, with OR
at unity again. Exposure to paints yielded 6 (5.6%) cases,
13(12.0%) familial controls and 7 (5.6%) hospital controls,
giving an OR of 0.43 (95% CI = 0.16 − 1.18, P = 0.093)
and OR of 0.85 (95%CI = 0.28 − 2.61, P = 0.76) respectively.
Exposure to solvents in motor vehicle repairs had 3 (2.8%)
cases, 2 (1.9%) familial and 4 (3.7%) hospital controls, giving
an OR of 1.51 (95% CI = 0.24 − 9.25, P = 0.65) and OR of
0.74 (95% CI = 0.16 − 3.40, P = 0.70), respectively.
Exposure to Pesticides
There were 46 (43.0%) cases exposed to pesticides in terms
of working on farms, gardens or as horticulturalists, either as
an occupation or as a hobby, compared to 36 (33.3%) in
familial control group and 46 (42.6%) patients in hospital
control group. This was found to be non-significant with
OR of 1.51 (95% CI = 0.87 − 2.62, P = 0.15) in comparison
to familial controls and OR 1.02 (95% CI = 0.59 − 1.75, P =
0.95) in comparison to hospital control group (Tables 2, 3).
The cases had a mean of 11.38±9.65 years (95%CI = 6.23 −
16.52) for exposure to benzene, compared to 7.95 ± 8.97 years
(95% CI = 3.63 − 12.27, P = 0.288) in familial control group
Fig. 2 Case distribution by age and gender
Table 1 Demographic characteristics of study subjects.
Cases Familial control P value Hospital control P value
Age in years
Mean 41.32 ± 15.34 41.07 ± 15.21 0.90 41.2 ± 15.09 0.95
Median 40.5 41.0 40.0
Occupation
Indoor 63.3% 73.5% 0.11 56.3% 0.33
Outdoor 36.7% 26.5% 43.7%
BMI
Mean 25.26 ± 6.25 25.04 ± 5.69 0.70 23.16 ± 4.41 0.08
Median 23.93 23.84 22.42
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Table 2 Odds ratios for exposure to benzene and pesticides.
Exposure factor Cases Familial control OR with 95% CI P value
Petroleum Yes 4 (3.7%) 4 (3.7%) 1 (0.24–4.11) 1.00
No 104 (96.3%) 104 (96.3%)
Plastic Yes 2 (1.9%) 2 (1.9%) 1.0 (0.14–1.18) 1.00
No 106 (98.1%) 106 (98.1%)
Paints Yes 6 (5.6%) 13 (12.0%) 0.43 (0.16–1.18) 0.093
No 102 (94.4%) 95 (88%)
Motor repair Yes 3 (2.8%) 2 (1.9%) 1.51 (0.24–9.25) 0.65
No 105 (97.2%) 106 (98.1%)
Pesticides Yes 46 (43.0%) 36 (33.3%) 1.51 (0.87–2.62) 0.15
No 62 (57.0%) 72 (66.7%)
Table 3 Odds ratios for exposure to benzene and pesticides.
Exposure Factor Cases Hospital control OR with 95% CI P value
Petroleum Yes 4 (3.7%) 4 (3.7%) 1 (0.24–4.11) 1.00
No 104 (96.3%) 104 (96.3%)
Plastic Yes 2 (1.9%) 0 (0.0%) 0.15
No 106 (98.1%) 108 (100.0%)
Paints Yes 6 (5.6%) 7 (6.5%) 0.85 (0.28–2.61) 0.76
No 102 (94.4%) 101 (93.5%)
Motor repair Yes 3 (2.8%) 4 (3.7%) 0.74 (0.16–3.40) 0.70
No 105 (97.2%) 104 (96.3%)
Pesticides Yes 46 (43.0%) 46 (42.6%) 1.02 (0.59–1.75) 0.95
No 62 (57.0%) 62 (57.4%)
Fig. 3 Duration of exposure to benzene and pesticides against status
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and 6.00 ± 4.35 years (95% CI = 3.49 − 8.51, P = 0.058) in
hospital control group. None of these reached statistically sig-
nificant levels.
Duration of exposure to pesticides in the cases had a mean
of 16.49 ± 17.31 years (95% CI = 11.41 − 21.57) compared
to the hospital-control mean duration of 16.09 ± 16.06 years
(95% CI = 11.26 − 20.91), but a statistically significant dif-
ference with P = 0.017 with familial control mean duration
of 9.50 ± 8.54 years (95% CI = 6.77 − 12.23) was observed
(Fig. 3) (Table 4).
Discussion
The median age for patients in this study is 41.32 with an age
range of 8–81 years. Othieno-Abinya et al found a similar
age range of 10–72 years in KNH in 2000 [18]. They found a
median age of 35 years at diagnosis whereas Bjork in Swe-
den found a median age of occurrence of CML at 51 years,
almost 10 years younger than our population [13]. Our male
to female ratio was 1.7:1, which is comparable to what
Othieno-Abinya and colleagues [18] found at 1.1:1 and
Bjork et al at 1.23:1 [13], which is in keeping with the gen-
eral observations.
Our peak age of occurrence of CML is 10 years younger
than in the West. The peak for females is even at a younger
age of 25–30 years, but the number is too small to make a
firm statement. Similar median age of 40 years for CML was
found in Nigeria [19], reflecting generally younger age of
occurrence of CML in Africa.
Other cancers in Africans have also been found to be
occurring at a younger age group, for example, median age
of occurrence of non-Hodgkin’s lymphoma in Kenya is only
32 years against the mean age of 50 years internationally [1].
It is not clear why we have an earlier age of occurrence of
CML and further studies are required to probe into the etio-
logic possibilities of this significant difference. The impor-
tant contributing factors could be genetic, environmental,
and socioeconomic.
Majority of the patients came from environs of Nairobi and
44.5% of our patients came from or had at one time lived in
Nairobi at least for a year. The patient population was concen-
trated proximal to health facility, particularly Nairobi, where
expertise, health personnel, and diagnostic facilities are avail-
able, and also ease of communication. Clinicians and physi-
cians outside Nairobi may not be aware of the GIPAP pro-
gram and may not be referring patients to the program. The
only far away pocket was seven patients coming from Mom-
basa district on the Coast of Kenya. This is the second largest
city in Kenya with a high population density and good infra-
structure and links to Nairobi. The pocket of patients from
North Eastern Kenya could be explained by links of people
from the province with Nairobi, particularly in the Eastleigh
area. Some areas in Southern Kenya yielded no cases and that
could possibly be explained by the healthcare-seeking behav-
ior of the communities living in those regions and possible
belief in traditional and herbal modes of treatment. Othieno-
Abinya and co-workers also had more than 35% of cases
being from Kikuyu tribe, and they thought it was possibly
due to proximity to Nairobi [18]. This is reflected in other
chronic disease outpatient clinics in KNH and is thought to
be due to the patient catchment area.
We found the OR for benzene exposure from petrochem-
icals plastic and rubber industries and exposure to paint were
close to unity in CML patients. Failure to stratify by intensity
or duration may have failed to show association of CML
with benzene. Longer duration of exposure, as found in the
cases, may probably be contributing to risk of developing
CML. The findings by Bjork and colleagues in Sweden
were similar [13].
This also agrees well with a combined cohort study of
petroleum workers in China, who were exposed to petro-
chemicals such as benzene at low concentrations and gaso-
line [20]. At higher concentration exposures, non-significant
effects of occupational exposure to benzene on leukemias
other than AML have, however, been reported. [21]
Yu and co-workers suggested a possible link between liv-
ing in an area with high exposure to airborne petrochemicals
(derivatives of petroleum or natural gas) and risk of develop-
ing leukemia in a study in Taiwan [22]. We only had one case
in our study residing in close proximity to an oil refinery.
The association between farming and leukemia in general,
which has been studied in numerous epidemiological settings,
is likely to be weak, if present at all [23]. Our data did not
indicate risk of CML associated with agricultural life, mani-
fested by OR estimates almost at unity for typical agricultural
exposures such as farming occupations and pesticides. The
OR was just above unity when compared with familial con-
trols. Duration of exposure to pesticides was similar with hos-
pital control but significantly lower in familial group. We
Table 4 Duration of exposure to benzene and pesticides.
Exposure Cases
(Mean years)
Familial control
(Mean years)
t-Test significance Hospital control
(Mean years)
t-Test significance
Benzene 11.38 7.95 0.288 6 0.058
Pesticides 16.49 9.5 0.017 16.09 0.909
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think this may be due to the general nature of agricultural
lifestyle in the hospital control group, who had a homogenous
distribution in the country.
A meta analysis by Belgian researchers to determine if
occupational exposure to pesticides was associated with a
higher risk of CML. Overall, the case-control studies indi-
cated a relative risk of 1.38 (95% CI = 1.06 − 1.79) of devel-
oping CML among farmers and agricultural workers exposed
to pesticides [24]. However, Bjork found the OR for exposure
to pesticides for Ph chromosome-positive CML patients in
Sweden to be 0.75 (95% CI = 0.42 − 1.3) [13].
Conclusion
Associations between exposures to organic solvents like pes-
ticides, creosote as used in timber preservation, water treat-
ment by chlorinated chemicals and Ph chromosome-positive
CML were indicated but were not entirely consistent.
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